Tyr185
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus®
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Tyr185  -  JNK2 (human)

Site Information
tNFMMtPyVVtRYYR   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 447652
Available spectra:  2 CST
Associated spectra:  1 CST

In vivo Characterization
Methods used to characterize site in vivo:
immunoprecipitation ( 252 , 479 ) , mass spectrometry ( 5 , 9 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 133 , 134 , 135 , 136 , 137 , 138 , 139 , 141 , 142 , 143 , 144 , 145 , 146 , 147 , 148 , 149 , 150 , 151 , 152 , 153 , 154 , 155 , 156 , 157 , 158 , 159 , 160 , 161 , 162 , 163 , 164 , 165 , 166 , 167 , 168 , 169 , 170 , 171 , 172 , 173 , 174 , 175 , 176 , 177 , 178 , 179 , 180 , 181 , 182 , 183 , 184 , 185 , 186 , 187 , 188 , 189 , 190 , 191 , 192 , 193 , 194 , 195 , 196 , 197 , 198 , 199 , 200 , 201 , 202 , 203 , 204 , 205 , 206 , 207 , 208 , 209 , 210 , 211 , 212 , 213 , 214 , 215 , 216 , 217 , 218 , 219 , 220 , 221 , 222 , 223 , 224 , 225 , 226 , 227 , 228 , 229 , 230 , 231 , 232 , 233 , 234 , 235 , 236 , 237 , 238 , 239 , 240 , 241 , 242 , 243 , 244 , 245 , 246 , 247 , 248 , 249 , 250 , 251 , 253 , 254 , 256 , 257 , 258 , 259 , 260 , 261 , 262 , 263 , 264 , 265 , 266 , 267 , 268 , 269 , 270 , 272 , 273 , 274 , 275 , 276 , 277 , 278 , 279 , 280 , 281 , 282 , 283 , 284 , 285 , 286 , 287 , 289 , 290 , 291 , 292 , 293 , 294 , 295 , 296 , 297 , 298 , 299 , 300 , 301 , 302 , 305 , 306 , 307 , 308 , 309 , 310 , 311 , 312 , 313 , 314 , 315 , 316 , 317 , 318 , 319 , 320 , 321 , 322 , 323 , 324 , 325 , 326 , 327 , 328 , 329 , 330 , 331 , 332 , 333 , 334 , 335 , 336 , 337 , 338 , 339 , 340 , 341 , 342 , 343 , 344 , 345 , 346 , 347 , 348 , 349 , 350 , 351 , 352 , 353 , 354 , 355 , 356 , 357 , 358 , 359 , 360 , 361 , 362 , 363 , 364 , 365 , 366 , 367 , 368 , 369 , 370 , 371 , 372 , 373 , 374 , 375 , 376 , 377 , 378 , 379 , 380 , 381 , 382 , 383 , 384 , 385 , 386 , 387 , 388 , 389 , 390 , 391 , 392 , 393 , 395 , 396 , 397 , 398 , 399 , 400 , 401 , 402 , 403 , 404 , 405 , 406 , 407 , 408 , 409 , 410 , 411 , 412 , 413 , 414 , 415 , 416 , 417 , 418 , 419 , 420 , 421 , 422 , 423 , 424 , 425 , 426 , 427 , 428 , 429 , 430 , 431 , 432 , 433 , 434 , 435 , 436 , 437 , 438 , 439 , 440 , 441 , 442 , 443 , 444 , 445 , 446 , 447 , 448 , 449 , 450 , 451 , 452 , 453 , 454 , 455 , 456 , 457 , 458 , 459 , 460 , 461 , 462 , 463 , 464 , 465 , 466 , 467 , 468 , 469 , 470 , 471 , 472 , 473 , 474 , 475 , 476 , 477 , 478 , 480 , 481 , 482 , 483 , 484 , 485 , 486 , 487 , 488 , 489 , 490 , 491 , 492 , 493 , 494 , 495 , 496 , 497 , 498 , 499 , 500 , 501 , 502 , 503 , 504 , 505 , 506 , 507 , 508 , 509 , 510 , 511 , 512 , 513 , 514 , 515 , 516 , 517 , 518 , 519 , 520 , 521 , 522 , 523 , 524 , 525 , 526 , 527 , 528 , 529 , 530 , 531 , 532 , 533 , 534 , 535 , 536 , 537 , 538 , 539 , 540 , 541 , 542 , 543 , 544 , 545 , 546 , 547 , 548 , 549 , 550 , 551 , 552 , 553 , 554 , 555 , 556 , 557 , 558 , 559 , 560 , 561 , 562 , 563 , 564 , 565 , 566 , 567 , 568 , 569 , 570 , 571 , 572 , 573 , 574 , 575 , 576 , 577 , 578 , 579 , 580 , 581 , 582 , 583 , 584 , 585 , 586 , 587 , 588 , 589 , 590 , 591 , 592 , 593 , 594 , 595 , 596 , 597 , 598 , 599 , 600 , 601 , 602 , 603 , 604 , 605 , 606 , 607 , 608 , 609 , 610 , 611 , 612 , 613 , 614 , 615 , 616 , 617 , 618 , 619 , 620 , 621 , 622 , 623 , 624 , 625 , 626 , 627 , 628 , 629 , 630 , 631 , 632 , 633 , 634 , 635 , 636 , 637 , 638 , 639 , 640 , 641 , 642 , 643 , 644 , 645 , 646 , 647 , 648 , 649 , 650 , 651 , 652 , 653 , 654 , 655 , 656 , 657 , 658 , 659 , 660 , 661 , 662 , 663 , 664 , 665 , 666 , 667 , 668 , 669 , 670 , 671 , 672 , 673 , 674 , 675 , 676 , 677 , 678 , 679 , 680 , 681 , 682 , 683 , 684 , 685 , 686 , 687 , 688 , 689 , 690 , 691 , 692 , 693 , 694 , 695 , 696 , 697 , 698 , 699 , 700 , 701 , 702 , 703 , 704 , 705 , 706 , 707 , 708 , 709 , 710 , 711 , 712 , 713 , 714 , 715 , 716 , 717 , 718 , 719 , 720 , 721 , 722 , 723 , 724 , 725 , 726 , 727 , 728 , 729 , 730 , 731 , 732 , 733 , 734 , 735 , 737 , 738 , 739 , 740 , 741 , 742 , 743 , 744 , 745 , 746 , 747 , 748 , 749 , 750 , 751 , 752 , 753 , 754 , 755 , 756 , 757 , 758 , 759 , 760 , 761 , 762 , 763 , 764 , 765 , 766 , 767 , 768 , 769 , 770 , 771 , 772 , 773 , 774 , 775 , 776 , 777 , 778 , 779 , 780 , 781 , 782 , 783 , 784 , 785 , 786 , 787 , 788 , 789 , 790 , 791 , 792 , 793 , 794 , 795 , 796 , 797 , 798 , 799 , 800 , 801 , 802 , 803 , 804 , 805 , 806 , 807 , 808 , 809 , 810 , 811 , 812 , 813 , 814 , 815 , 816 , 817 , 818 , 819 , 820 , 821 , 822 , 824 , 826 , 827 , 828 , 829 , 830 , 831 , 832 , 833 , 834 , 835 , 836 , 838 , 839 , 840 , 841 , 842 , 843 , 844 , 845 , 846 , 847 , 848 , 849 , 850 , 851 , 852 , 853 , 854 , 855 , 856 , 857 , 858 , 859 , 860 , 861 , 862 , 863 , 864 , 865 , 866 , 867 , 868 , 869 , 870 , 872 , 873 , 874 , 875 , 876 , 877 , 879 , 880 , 881 , 882 , 883 , 884 , 885 , 886 , 887 , 888 , 889 , 890 , 891 , 892 , 893 , 894 , 895 , 896 , 897 , 898 , 899 , 900 , 901 , 902 , 903 , 904 , 905 , 906 , 907 , 908 , 909 , 910 , 911 , 912 , 913 , 914 , 915 , 916 , 917 , 918 , 919 , 920 , 921 , 922 , 923 , 924 , 925 , 926 , 927 , 928 , 929 , 930 , 931 , 932 , 933 , 934 , 935 , 936 , 937 , 938 , 939 , 940 , 941 , 942 , 943 , 944 , 945 , 946 , 947 , 948 , 949 , 950 , 951 , 952 , 953 , 954 , 955 , 956 , 957 , 958 , 959 , 960 , 961 , 962 , 963 , 964 , 965 , 966 , 967 , 968 , 969 , 970 , 971 , 972 , 973 , 974 , 975 , 976 , 977 , 978 , 979 , 980 , 981 , 982 , 983 , 984 , 985 , 986 , 987 , 988 , 989 , 990 , 991 , 992 , 993 , 995 , 996 , 997 , 998 , 999 , 1000 , 1001 , 1002 , 1003 , 1004 , 1005 , 1006 , 1007 , 1008 , 1009 , 1010 , 1011 , 1012 , 1014 , 1016 , 1017 , 1019 , 1020 , 1021 , 1022 , 1023 , 1024 , 1025 , 1026 , 1027 , 1028 , 1029 , 1030 , 1031 , 1032 , 1033 , 1034 , 1035 , 1036 , 1037 , 1038 , 1039 , 1040 , 1041 , 1043 , 1044 , 1045 , 1046 , 1047 , 1048 , 1049 , 1050 , 1051 , 1052 , 1053 , 1054 , 1055 , 1056 , 1057 , 1058 , 1059 , 1060 , 1061 , 1062 , 1063 , 1064 , 1065 , 1066 , 1068 , 1069 , 1070 , 1071 , 1072 , 1073 , 1074 , 1075 , 1076 , 1077 , 1078 , 1079 , 1080 , 1081 , 1082 , 1084 , 1085 , 1086 , 1087 , 1088 , 1089 , 1090 , 1091 , 1092 , 1093 , 1094 , 1095 , 1096 , 1097 , 1098 , 1099 , 1100 , 1101 , 1102 , 1103 , 1104 , 1105 , 1106 , 1107 , 1108 , 1109 , 1110 , 1111 , 1112 , 1113 , 1114 , 1115 , 1116 , 1117 , 1118 , 1119 , 1120 , 1121 , 1122 , 1123 , 1124 , 1125 , 1126 , 1127 , 1128 , 1129 , 1130 , 1131 , 1132 , 1133 , 1134 , 1135 , 1136 , 1137 , 1138 , 1139 , 1140 , 1141 , 1142 , 1143 , 1144 , 1145 , 1146 , 1147 , 1148 , 1149 , 1150 , 1151 , 1152 , 1153 , 1154 , 1155 , 1156 , 1157 , 1158 , 1159 , 1160 , 1161 , 1162 , 1163 , 1164 , 1165 , 1166 , 1167 , 1168 , 1169 , 1170 , 1171 , 1172 , 1173 , 1174 , 1175 , 1176 , 1177 , 1178 , 1179 , 1180 , 1181 , 1182 , 1183 , 1184 , 1185 , 1186 , 1187 , 1188 , 1189 , 1190 , 1191 , 1192 , 1193 , 1194 , 1195 , 1196 , 1197 , 1198 , 1199 , 1201 , 1202 , 1203 , 1204 , 1205 , 1206 , 1207 , 1208 , 1209 , 1210 , 1211 , 1212 , 1214 , 1215 , 1216 , 1217 , 1218 , 1219 , 1220 , 1221 , 1222 , 1223 , 1224 , 1225 , 1226 , 1227 , 1228 , 1229 , 1230 , 1232 , 1234 , 1235 , 1236 , 1237 , 1238 , 1239 , 1240 , 1241 , 1242 , 1243 , 1244 , 1245 , 1246 , 1247 , 1248 , 1249 , 1250 , 1251 , 1253 , 1254 , 1257 , 1258 , 1259 , 1260 , 1261 , 1262 , 1263 , 1264 ) , microscopy-colocalization with upstream kinase ( 1042 ) , mutation of modification site ( 2 , 1233 ) , phospho-antibody ( 1 , 2 , 3 , 4 , 7 , 8 , 10 , 11 , 12 , 13 , 14 , 15 , 92 , 252 , 271 , 288 , 303 , 304 , 394 , 479 , 823 , 825 , 837 , 871 , 878 , 994 , 1013 , 1015 , 1042 , 1067 , 1083 , 1200 , 1213 , 1233 , 1252 , 1255 , 1256 , 1265 , 1266 , 1267 , 1268 , 1269 ) , western blotting ( 1 , 2 , 3 , 4 , 7 , 8 , 10 , 11 , 12 , 13 , 14 , 15 , 92 , 252 , 271 , 288 , 303 , 304 , 394 , 479 , 823 , 825 , 837 , 871 , 878 , 994 , 1013 , 1015 , 1042 , 1067 , 1083 , 1200 , 1213 , 1267 , 1268 , 1269 )
Disease tissue studied:
atrial fibrillation ( 959 , 966 , 976 , 977 , 978 , 979 , 987 ) , bile-duct cancer ( 788 , 790 ) , bladder cancer ( 325 , 330 , 1089 , 1091 , 1135 ) , bladder cancer, surrounding tissue ( 516 , 519 , 520 ) , bone cancer ( 34 , 1015 , 1019 , 1020 , 1043 , 1044 ) , Ewing's sarcoma ( 1043 ) , osteosarcoma ( 34 , 1019 , 1020 , 1044 ) , brain cancer ( 16 , 34 , 145 , 146 , 154 , 207 , 288 , 476 , 477 , 478 , 818 , 875 , 876 , 885 , 886 , 1099 , 1133 , 1150 , 1189 , 1191 , 1195 , 1208 , 1224 ) , astrocytoma ( 145 , 146 , 154 , 818 , 1133 , 1189 , 1191 ) , glioblastoma ( 16 , 207 , 288 , 476 , 477 , 478 , 1099 , 1150 , 1195 , 1208 , 1224 ) , glioblastoma multiforme ( 875 , 876 , 885 , 886 , 1150 , 1195 , 1208 ) , glioma ( 16 , 207 , 288 , 476 , 477 , 478 , 875 , 876 , 885 , 886 , 1099 , 1150 , 1195 , 1208 , 1224 ) , Schwannoma ( 34 ) , breast cancer ( 18 , 208 , 209 , 278 , 318 , 394 , 512 , 513 , 514 , 515 , 517 , 518 , 627 , 837 , 941 , 942 , 943 , 944 , 945 , 946 , 947 , 948 , 949 , 950 , 951 , 952 , 953 , 954 , 955 , 956 , 957 , 958 , 967 , 968 , 969 , 981 , 1007 , 1008 , 1009 , 1010 , 1011 , 1045 , 1046 , 1048 , 1058 , 1059 , 1102 , 1103 , 1107 , 1108 , 1112 , 1113 , 1114 , 1115 , 1116 , 1124 , 1138 , 1143 , 1194 , 1201 , 1261 , 1267 ) , breast ductal carcinoma ( 18 , 1194 , 1201 ) , HER2 positive breast cancer ( 5 ) , luminal A breast cancer ( 5 ) , luminal B breast cancer ( 5 ) , breast cancer, surrounding tissue ( 318 , 512 , 514 , 517 ) , breast cancer, triple negative ( 5 , 18 , 1102 , 1103 , 1201 ) , cervical cancer ( 1269 ) , cervical squamous cell carcinoma ( 1269 ) , colorectal cancer ( 66 , 67 , 68 , 139 , 153 , 258 , 260 , 276 , 304 , 314 , 324 , 327 , 329 , 733 , 735 , 737 , 772 , 774 , 1016 , 1017 , 1146 , 1147 , 1148 , 1154 , 1166 , 1167 , 1168 , 1169 , 1267 ) , colorectal carcinoma ( 66 , 67 , 68 , 153 , 304 , 329 , 1016 , 1017 , 1146 , 1147 , 1148 , 1166 , 1167 , 1168 , 1169 , 1267 ) , colorectal cancer, surrounding tissue ( 261 , 272 , 323 , 328 , 727 , 728 , 729 , 732 , 734 , 738 , 770 , 934 , 935 , 937 , 938 , 939 ) , esophageal cancer ( 54 , 55 , 56 , 355 , 358 , 359 , 360 , 361 , 362 , 363 , 364 , 365 , 366 , 618 , 619 , 623 , 634 , 635 , 637 , 639 , 647 , 650 , 651 , 654 , 655 , 656 , 660 , 661 , 662 , 664 , 668 , 671 , 676 , 678 , 680 , 681 , 684 , 685 , 686 , 687 , 689 , 691 , 694 , 696 , 697 , 701 , 705 , 706 , 707 , 712 , 713 , 714 , 715 , 719 , 720 , 1136 ) , esophageal carcinoma ( 355 , 358 , 359 , 360 , 361 , 362 , 363 , 365 ) , esophageal cancer, surrounding tissue ( 333 , 633 , 636 , 638 , 640 , 641 , 642 , 643 , 644 , 645 , 646 , 648 , 649 , 652 , 653 , 657 , 658 , 659 , 663 , 665 , 666 , 667 , 669 , 670 , 672 , 673 , 674 , 675 , 677 , 679 , 682 , 683 , 688 , 690 , 692 , 693 , 695 , 698 , 699 , 703 , 708 , 709 , 710 , 711 , 716 , 717 , 718 , 721 , 722 ) , liposarcoma ( 34 ) , gastric cancer ( 31 , 44 , 45 , 87 , 88 , 89 , 132 , 133 , 134 , 135 , 315 , 356 , 402 , 482 , 484 , 486 , 487 , 489 , 490 , 491 , 492 , 493 , 494 , 498 , 499 , 501 , 502 , 503 , 839 , 841 , 842 , 845 , 847 , 848 , 851 , 856 , 859 , 862 , 864 , 865 , 971 , 973 , 974 , 984 , 986 , 988 , 991 , 993 , 1005 , 1006 , 1012 , 1149 ) , gastric carcinoma ( 87 , 88 , 89 , 132 , 133 , 134 , 135 , 315 , 356 , 839 , 841 , 842 , 845 , 847 , 848 , 851 , 971 , 973 , 974 , 988 , 991 , 993 , 1012 , 1149 ) , gastric carcinoma, surrounding tissue ( 483 , 485 , 488 , 495 , 496 , 497 , 500 , 504 , 838 , 840 , 843 , 844 , 846 , 849 , 850 , 855 , 857 , 858 , 863 , 866 , 867 , 970 , 972 , 982 , 983 , 985 , 990 , 1001 ) , kidney cancer ( 523 , 536 , 538 , 540 , 550 , 1021 ) , kidney cancer, surrounding tissue ( 526 , 539 , 549 , 551 ) , leukemia ( 7 , 19 , 244 , 245 , 246 , 247 , 248 , 249 , 305 , 306 , 388 , 393 , 424 , 426 , 427 , 428 , 429 , 430 , 431 , 432 , 433 , 434 , 435 , 436 , 437 , 447 , 448 , 449 , 450 , 561 , 1038 , 1039 , 1040 , 1041 , 1049 , 1050 , 1051 , 1052 , 1053 , 1065 , 1118 , 1119 , 1120 , 1121 , 1122 , 1129 , 1157 , 1158 , 1164 , 1165 , 1170 , 1171 , 1173 , 1182 , 1210 , 1232 , 1268 ) , acute lymphocytic leukemia ( 256 ) , acute myelogenous leukemia ( 7 , 256 , 561 , 1049 , 1050 , 1051 , 1052 , 1053 , 1065 , 1118 , 1119 , 1120 , 1121 , 1122 , 1129 , 1157 , 1158 , 1165 , 1170 , 1171 , 1173 , 1182 , 1232 , 1268 ) , chronic lymphocytic leukemia ( 19 , 1210 ) , chronic myelogenous leukemia ( 244 , 245 , 246 , 247 , 248 , 249 , 305 , 306 , 388 , 393 , 424 , 426 , 427 , 428 , 429 , 430 , 431 , 432 , 433 , 434 , 435 , 436 , 437 , 447 , 448 , 449 , 450 , 1164 ) , liver cancer ( 253 , 334 , 336 , 337 , 338 , 339 , 340 , 341 , 342 , 343 , 344 , 345 , 346 , 348 , 349 , 350 , 351 , 522 , 527 , 528 , 537 , 552 , 554 , 557 , 558 , 559 , 565 , 566 , 567 , 568 , 569 , 571 , 573 , 574 , 578 , 582 , 584 , 585 , 588 , 590 , 597 , 600 , 601 , 602 , 607 , 611 , 613 , 725 , 726 , 741 , 743 , 746 , 748 , 749 , 750 , 753 , 755 , 756 , 757 , 768 , 769 , 771 , 787 , 789 , 820 , 821 , 822 , 872 , 873 , 874 , 912 , 917 , 918 , 921 , 923 , 926 , 927 , 994 , 1003 ) , liver adenocarcinoma ( 726 ) , cholangiocellular carcinoma ( 253 , 559 , 601 , 746 , 769 , 771 , 872 ) , cholangiocellular carcinoma, surrounding tissue ( 564 , 580 , 752 , 765 , 766 , 922 , 929 ) , hepatocellular carcinoma ( 552 , 554 , 557 , 558 , 565 , 566 , 567 , 568 , 569 , 571 , 573 , 574 , 578 , 582 , 584 , 585 , 588 , 590 , 597 , 600 , 602 , 607 , 611 , 613 , 741 , 748 , 749 , 750 , 753 , 756 , 757 , 768 , 873 , 912 , 917 , 918 , 921 , 923 , 926 , 927 , 1003 ) , hepatocellular carcinoma, surrounding tissue ( 553 , 555 , 556 , 570 , 572 , 575 , 576 , 577 , 581 , 583 , 586 , 587 , 589 , 591 , 592 , 593 , 594 , 595 , 598 , 599 , 604 , 606 , 608 , 742 , 744 , 745 , 747 , 751 , 767 , 908 , 909 , 916 , 919 , 924 , 928 , 1002 , 1004 ) , liver cancer, surrounding tissue ( 335 , 347 , 521 , 524 , 525 , 596 , 603 ) , lung cancer ( 1 , 8 , 17 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 39 , 40 , 41 , 42 , 43 , 52 , 65 , 92 , 141 , 142 , 143 , 144 , 147 , 148 , 149 , 150 , 151 , 152 , 158 , 159 , 160 , 161 , 162 , 163 , 164 , 165 , 166 , 167 , 168 , 169 , 170 , 172 , 201 , 203 , 205 , 250 , 251 , 252 , 273 , 298 , 354 , 375 , 377 , 378 , 379 , 380 , 382 , 383 , 384 , 385 , 386 , 389 , 390 , 391 , 396 , 397 , 400 , 401 , 403 , 404 , 451 , 453 , 454 , 456 , 457 , 460 , 463 , 464 , 465 , 466 , 467 , 469 , 471 , 472 , 474 , 541 , 614 , 615 , 616 , 617 , 620 , 621 , 622 , 624 , 730 , 731 , 740 , 775 , 776 , 777 , 778 , 779 , 780 , 781 , 814 , 819 , 824 , 825 , 826 , 853 , 861 , 868 , 869 , 870 , 878 , 936 , 989 , 1012 , 1013 , 1014 , 1047 , 1060 , 1061 , 1062 , 1063 , 1068 , 1069 , 1070 , 1071 , 1072 , 1073 , 1074 , 1075 , 1076 , 1077 , 1078 , 1079 , 1080 , 1081 , 1082 , 1084 , 1085 , 1086 , 1087 , 1090 , 1117 , 1123 , 1125 , 1128 , 1130 , 1131 , 1132 , 1137 , 1139 , 1140 , 1141 , 1142 , 1144 , 1145 , 1155 , 1159 , 1161 , 1162 , 1172 , 1174 , 1175 , 1176 , 1177 , 1178 , 1183 , 1184 , 1185 , 1186 , 1187 , 1188 , 1190 , 1192 , 1193 , 1196 , 1199 , 1202 , 1205 , 1206 , 1211 , 1212 , 1214 , 1215 , 1218 , 1219 , 1220 , 1221 , 1222 , 1223 , 1225 , 1226 , 1227 , 1228 , 1229 , 1230 , 1234 , 1235 , 1238 , 1239 , 1240 , 1241 , 1242 , 1245 , 1246 , 1249 , 1251 , 1253 , 1263 , 1267 ) , non-small cell lung cancer ( 1 , 8 , 17 , 21 , 22 , 23 , 25 , 26 , 27 , 29 , 32 , 39 , 40 , 41 , 42 , 43 , 52 , 65 , 141 , 142 , 143 , 144 , 147 , 148 , 149 , 150 , 151 , 152 , 158 , 159 , 160 , 161 , 162 , 163 , 164 , 165 , 166 , 167 , 168 , 169 , 170 , 172 , 250 , 251 , 252 , 298 , 396 , 397 , 400 , 401 , 451 , 453 , 454 , 456 , 457 , 460 , 463 , 464 , 465 , 466 , 467 , 469 , 471 , 472 , 474 , 541 , 622 , 730 , 731 , 740 , 775 , 776 , 777 , 778 , 814 , 819 , 826 , 853 , 861 , 868 , 869 , 936 , 989 , 1012 , 1013 , 1014 , 1047 , 1060 , 1061 , 1068 , 1069 , 1070 , 1071 , 1072 , 1073 , 1074 , 1075 , 1076 , 1077 , 1080 , 1081 , 1082 , 1087 , 1117 , 1123 , 1125 , 1128 , 1130 , 1131 , 1132 , 1139 , 1140 , 1141 , 1142 , 1144 , 1145 , 1155 , 1159 , 1161 , 1162 , 1172 , 1174 , 1175 , 1176 , 1178 , 1188 , 1190 , 1193 , 1202 , 1205 , 1206 , 1211 , 1214 , 1215 , 1218 , 1219 , 1220 , 1221 , 1222 , 1223 , 1225 , 1226 , 1227 , 1228 , 1229 , 1230 , 1234 , 1235 , 1239 , 1240 , 1241 , 1242 , 1245 , 1246 , 1249 , 1251 , 1253 , 1263 ) , non-small cell lung cancer, surrounding tissue ( 398 , 399 , 754 , 854 , 860 ) , non-small cell lung adenocarcinoma ( 8 , 17 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 29 , 52 , 65 , 142 , 143 , 144 , 149 , 150 , 151 , 152 , 158 , 159 , 160 , 161 , 162 , 163 , 164 , 165 , 166 , 167 , 168 , 169 , 170 , 172 , 250 , 252 , 298 , 354 , 451 , 453 , 454 , 456 , 457 , 460 , 463 , 464 , 465 , 466 , 467 , 469 , 471 , 472 , 474 , 730 , 775 , 776 , 777 , 778 , 819 , 868 , 869 , 936 ) , non-small cell lung adenocarcinoma, surrounding tissue ( 171 , 452 , 455 , 458 , 459 , 461 , 462 , 468 , 470 , 473 ) , non-small cell large cell lung carcinoma ( 22 , 25 , 1090 ) , non-small cell squamous cell lung carcinoma ( 1 , 24 , 32 , 52 , 614 , 615 , 616 , 617 , 620 , 621 , 624 , 730 , 779 , 780 , 781 , 870 , 1211 , 1221 ) , small-cell lung cancer ( 20 , 1192 ) , lung cancer, surrounding tissue ( 198 , 199 , 200 , 202 , 204 , 274 , 277 , 322 , 326 , 331 , 332 , 376 , 381 , 387 ) , lymphoma ( 1105 , 1106 , 1151 , 1152 , 1179 , 1180 , 1247 ) , anaplastic large cell lymphoma ( 1247 ) , B cell lymphoma ( 1179 , 1180 ) , Hodgkin's lymphoma ( 1105 , 1106 , 1151 , 1152 ) , neuroblastoma ( 9 , 265 , 266 , 296 , 297 , 1100 , 1101 , 1134 ) , oropharyngeal cancer ( 825 ) , squamous cell carcinoma of the oropharynx ( 825 ) , ovarian cancer ( 210 , 262 , 263 , 264 , 279 , 280 , 281 , 282 , 283 , 284 , 285 , 286 , 287 , 294 , 295 , 367 , 368 , 369 , 370 , 371 , 372 , 373 , 374 , 405 , 408 , 409 , 410 , 411 , 412 , 413 , 414 , 415 , 416 , 417 , 418 , 419 , 420 , 421 , 422 , 423 , 1023 , 1024 , 1025 , 1026 , 1028 , 1029 , 1030 , 1031 , 1153 , 1203 ) , ovarian epithelial carcinoma ( 210 , 262 , 294 , 295 ) , pancreatic cancer ( 4 , 625 , 1262 ) , pancreatic carcinoma ( 4 , 1262 ) , pancreatic cancer, surrounding tissue ( 626 , 980 ) , multiple myeloma ( 1181 ) , prostate cancer ( 4 , 271 , 823 ) , salivary gland cancer ( 797 , 798 , 799 , 800 , 801 , 802 , 803 , 804 , 805 , 806 , 807 , 808 ) , melanoma skin cancer ( 14 , 438 , 439 , 440 , 441 , 442 , 443 , 444 , 445 , 446 , 773 , 784 , 785 , 786 , 815 , 816 , 889 , 890 , 891 , 892 ) , leiomyosarcoma ( 34 ) , rhabdomyosarcoma ( 34 ) , teratoma ( 395 , 904 , 907 ) , teratoma, surrounding tissue ( 903 ) , thymic carcinoma ( 178 , 179 ) , thyroid cancer ( 906 , 960 , 961 , 995 , 996 , 997 , 998 , 999 ) , thyroid cancer, surrounding tissue ( 905 , 962 ) , ventricular tachycardia ( 180 , 181 , 182 , 183 , 184 , 185 , 186 , 187 , 188 , 189 , 190 , 191 , 192 , 193 , 211 , 212 , 213 , 214 , 215 , 216 , 217 , 218 , 219 , 220 , 221 , 222 , 223 , 224 , 225 , 226 , 227 , 228 , 229 , 230 , 231 , 232 , 233 , 234 , 235 , 236 , 237 , 238 , 239 , 240 , 241 , 242 , 243 ) , hypersplenism ( 992 )
Relevant cell line - cell type - tissue:
'fat, white' ( 34 ) , 'heart, papillary muscle' ( 911 ) , 'liver, para-cholangiocellular carcinoma tissue' ( 253 ) , 184A1 (epithelial) ( 605 ) , 23132/87 (gastric) ( 45 , 1149 ) , 23132/87 (gastric) [RAIG1 (human), knockdown] ( 44 ) , 293 (epithelial) ( 579 , 878 , 994 , 1015 , 1269 ) , 293 (epithelial) [EFNB1 (human), transfection] ( 425 ) , 293 (epithelial) [FGFR1 (human), transfection] ( 579 ) , 293T (epithelial) ( 304 , 791 , 792 , 793 , 794 , 795 , 796 , 837 , 1257 , 1258 , 1259 ) , 704773 (pulmonary) ( 378 ) , A375 (melanocyte) ( 14 ) , A431 (epithelial) ( 479 ) , A549 (pulmonary) ( 8 , 21 , 65 , 354 , 825 , 878 , 1013 , 1062 , 1063 , 1267 ) , A549 (pulmonary) [LKB1 (human), no information] ( 936 ) , ACC-S (adenoidal) ( 827 , 828 ) , artery ( 1213 ) , B lymphoid-blood ( 1210 ) , BAEC (endothelial) ( 1252 ) , BaF3 ('B lymphocyte, precursor') ( 1268 ) , BEAS-2B (epithelial) ( 758 , 759 ) , BEAS-2B (epithelial) [LKB1 (human), no information] ( 760 , 761 ) , bladder ( 325 , 330 , 516 , 519 , 520 ) , bone marrow ( 256 , 561 , 1049 , 1050 , 1051 , 1052 , 1053 , 1065 ) , brain ( 1150 ) , breast ( 5 , 18 , 208 , 209 , 278 , 318 , 512 , 513 , 514 , 515 , 517 , 518 , 941 , 942 , 943 , 944 , 945 , 946 , 947 , 948 , 949 , 950 , 951 , 952 , 953 , 954 , 955 , 956 , 957 , 958 , 967 , 968 , 969 , 981 , 1007 , 1008 , 1009 , 1010 , 1011 , 1045 , 1046 , 1048 , 1107 , 1108 , 1112 , 1113 , 1114 , 1115 , 1116 , 1124 ) , BT-474 (breast cell) ( 627 ) , BxPC-3 (pancreatic) ( 4 ) , CAD (neuron) ( 1042 ) , Caki-2 (renal) ( 1111 ) , Cal-12T (pulmonary) ( 27 ) , CAL-29 (bladder cell) ( 1091 ) , Calu-3 (pulmonary) ( 23 , 250 ) , cardiac-heart ( 212 , 218 , 219 , 223 , 226 , 230 , 231 , 233 , 238 , 242 ) , CAS-1 (glial) ( 1099 ) , cholangiocyte-liver ( 559 , 601 , 746 , 769 , 771 ) , CHRF (megakaryocyte) ( 1129 , 1232 ) , CMK (megakaryoblast) ( 1171 ) , COLO-680N (esophageal) ( 56 , 366 , 1136 ) , COLO-680N (esophageal) [RAIG1 (human), knockdown] ( 54 , 55 ) , colon ( 258 , 260 , 261 , 272 , 276 , 314 , 323 , 324 , 327 , 328 , 329 , 727 , 728 , 729 , 732 , 733 , 734 , 735 , 737 , 738 , 770 , 772 , 774 , 934 , 935 , 937 , 938 , 939 ) , DBTRG-05MG (glial) ( 1208 ) , Detroit562 (squamous) ( 825 ) , DLD1 (intestinal) ( 139 ) , DMS153 (pulmonary) ( 26 ) , DMS53 (pulmonary) ( 20 ) , DU 145 (prostate cell) ( 4 , 1233 ) , DV-90 (pulmonary) ( 1137 ) , EFM-19 (breast cell) ( 1126 ) , esophagus ( 333 , 618 , 619 , 623 , 633 , 634 , 635 , 636 , 637 , 638 , 639 , 640 , 641 , 642 , 643 , 644 , 645 , 646 , 647 , 648 , 649 , 650 , 651 , 652 , 653 , 654 , 655 , 656 , 657 , 658 , 659 , 660 , 661 , 662 , 663 , 664 , 665 , 666 , 667 , 668 , 669 , 670 , 671 , 672 , 673 , 674 , 675 , 676 , 677 , 678 , 679 , 680 , 681 , 682 , 683 , 684 , 685 , 686 , 687 , 688 , 689 , 690 , 691 , 692 , 693 , 694 , 695 , 696 , 697 , 698 , 699 , 701 , 703 , 705 , 706 , 707 , 708 , 709 , 710 , 711 , 712 , 713 , 714 , 715 , 716 , 717 , 718 , 719 , 720 , 721 , 722 ) , EVSA-T (breast cell) ( 1138 ) , F15R-Kit (T lymphocyte) ( 19 ) , FU-OV-1 (ovarian) ( 1153 ) , FU97 (gastric) ( 402 ) , germ cell-teratoma ( 903 , 904 , 907 ) , GI-CA-N (neural crest) ( 9 , 1100 ) , glial-brain ( 16 ) , H4IIe (hepatic) ( 994 ) , HaCaT (keratinocyte) ( 1015 ) , HCC1143 (breast cell) ( 1201 ) , HCC1395 (breast cell) ( 1194 ) , HCC15 (pulmonary) ( 24 ) , HCC202 (breast cell) ( 1058 , 1059 ) , HCC366 (pulmonary) ( 1251 ) , HCC38 (breast cell) ( 1102 ) , HCC44 (pulmonary) ( 27 , 1241 ) , HCC70 (breast cell) ( 1103 ) , HCC78 (pulmonary) ( 25 , 143 , 144 , 151 , 152 , 819 ) , HCC827 (pulmonary) ( 23 , 252 , 298 ) , HCT116 (intestinal) ( 66 , 67 , 68 , 153 , 304 , 610 , 1148 , 1267 ) , HCT15 (intestinal) ( 1166 , 1167 ) , HCT8 (intestinal) ( 1168 , 1169 ) , HDLM-2 (lymphoid) ( 1106 , 1151 ) , heart ( 180 , 181 , 182 , 183 , 184 , 185 , 186 , 187 , 188 , 189 , 190 , 191 , 192 , 193 , 211 , 213 , 214 , 215 , 216 , 217 , 220 , 221 , 222 , 224 , 225 , 227 , 228 , 229 , 232 , 234 , 235 , 236 , 237 , 239 , 240 , 241 , 243 , 933 , 959 , 963 , 964 , 965 , 966 , 975 , 976 , 977 , 978 , 979 , 987 ) , HEL (erythroid) ( 1165 ) , HeLa (cervical) ( 11 , 303 , 357 , 406 , 877 ) , hepatic-'liver, para-cholangiocellular carcinoma tissue' ( 564 , 580 , 752 , 765 , 766 , 922 , 929 ) , hepatic-'liver, para-hepatocellular carcinoma tissue' ( 553 , 555 , 556 , 570 , 572 , 575 , 576 , 577 , 581 , 583 , 586 , 587 , 589 , 591 , 592 , 593 , 594 , 595 , 598 , 599 , 604 , 606 , 608 , 742 , 744 , 745 , 747 , 751 , 767 , 908 , 909 , 916 , 919 , 924 , 928 , 1002 , 1004 ) , hepatocyte-liver ( 2 , 552 , 554 , 557 , 558 , 565 , 566 , 567 , 568 , 569 , 571 , 573 , 574 , 578 , 582 , 584 , 585 , 588 , 597 , 600 , 602 , 607 , 741 , 748 , 749 , 753 , 768 , 912 , 917 , 918 , 921 , 923 , 926 , 927 , 1003 ) , HepG2 (hepatic) ( 613 ) , HES-3 ('stem, embryonic') ( 254 ) , HL60 (myeloid) ( 7 ) , HLE (hepatic) ( 756 ) , HLF (hepatic) ( 611 ) , HOS (bone cell) ( 1020 , 1266 ) , HuCCT1 (hepatic) ( 872 ) , Huh1 (hepatic) ( 757 ) , Huh28 (hepatic) ( 821 ) , Huh7 (hepatic) ( 874 ) , HUVEC (endothelial) ( 15 , 829 , 830 , 831 , 832 , 833 , 834 , 835 , 836 , 871 , 1067 , 1200 , 1252 ) , J82 (bladder cell) ( 1127 ) , JHH-2 (hepatic) ( 822 ) , JHH-4 (hepatic) ( 787 ) , JHH-6 (hepatic) ( 820 ) , JPM50.6 (T lymphocyte) ( 1083 ) , Jurkat (T lymphocyte) ( 28 , 35 , 47 , 48 , 49 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 69 , 70 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 90 , 91 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 136 , 137 , 138 , 155 , 156 , 157 , 173 , 174 , 175 , 176 , 177 , 194 , 195 , 196 , 197 , 206 , 257 , 259 , 267 , 268 , 269 , 270 , 275 , 289 , 290 , 291 , 292 , 293 , 301 , 302 , 307 , 308 , 309 , 310 , 311 , 312 , 313 , 316 , 317 , 352 , 353 , 392 , 407 , 475 , 480 , 481 , 505 , 506 , 507 , 508 , 509 , 510 , 511 , 529 , 530 , 531 , 532 , 533 , 534 , 535 , 542 , 543 , 544 , 545 , 546 , 547 , 548 , 560 , 562 , 563 , 609 , 612 , 628 , 723 , 724 , 739 , 763 , 764 , 782 , 783 , 812 , 813 , 817 , 852 , 879 , 880 , 881 , 882 , 883 , 884 , 887 , 888 , 893 , 894 , 895 , 896 , 897 , 898 , 899 , 900 , 901 , 902 , 910 , 913 , 914 , 920 , 925 , 1000 , 1022 , 1064 , 1066 , 1083 , 1204 , 1256 , 1260 ) , Jurkat E6-1 (T lymphocyte) ( 30 ) , K562 (erythroid) ( 244 , 245 , 246 , 247 , 248 , 249 , 305 , 306 , 388 , 393 , 424 , 426 , 427 , 428 , 429 , 430 , 431 , 432 , 433 , 434 , 435 , 436 , 437 , 447 , 448 , 449 , 450 , 1164 ) , Karpas-1106P (B lymphocyte) ( 1180 ) , KB (squamous) ( 1269 ) , keratinocyte ( 1015 ) , kidney ( 523 , 526 , 536 , 538 , 539 , 540 , 549 , 550 , 551 , 1021 ) , KMS-27 (B lymphocyte) ( 1181 ) , KPL-1 (breast cell) ( 1143 ) , KURAMOCHI (ovarian) ( 286 ) , Kyse140 (esophageal) ( 363 ) , Kyse150 (esophageal) ( 358 ) , Kyse180 (esophageal) ( 365 ) , Kyse270 (esophageal) ( 361 ) , Kyse30 (esophageal) ( 355 ) , Kyse410 (esophageal) ( 362 ) , Kyse450 (squamous) ( 364 ) , Kyse510 (esophageal) ( 360 ) , Kyse520 (esophageal) ( 359 ) , L428 (lymphoid) ( 1105 , 1152 ) , LAN-1 (neural crest) ( 9 , 1101 ) , LAN-6 (neural crest) ( 9 ) , LCLC-103H (pulmonary) ( 1139 ) , liver ( 2 , 253 , 334 , 335 , 336 , 342 , 344 , 347 , 348 , 350 , 351 , 521 , 522 , 524 , 525 , 527 , 528 , 537 , 590 , 596 , 603 , 743 , 750 , 994 ) , LN18 (glial) ( 875 , 876 , 885 , 886 , 1195 ) , LN229 (glial) ( 288 ) , LN405 (glial) ( 1133 ) , LN428_LNZ308 (glial) [EGFR (human), transfection, EGFR (wildtype)] ( 207 ) , LN428_LNZ308 (glial) [EGFR (human), transfection, EGFRvIII mutant (aka Delta EGFR, d2-7 EGFR; del. exon 2-7; in-frame loss 801 bp/267 aa in EC domain)] ( 207 ) , LN428_LNZ308 (glial) [EGFR (human), transfection, EGFRvIII-ki mutant (deletion of exons 2-7 plus kinase inactive mutation)] ( 207 ) , LN444 (glial) ( 476 , 477 , 478 ) , LNCaP (prostate cell) ( 271 ) , LOU-NH91 (squamous) ( 24 , 1221 ) , lung ( 17 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 158 , 159 , 160 , 161 , 162 , 163 , 164 , 165 , 166 , 167 , 168 , 169 , 170 , 171 , 172 , 198 , 199 , 200 , 201 , 202 , 203 , 204 , 205 , 273 , 274 , 277 , 322 , 326 , 331 , 332 , 375 , 376 , 377 , 379 , 380 , 381 , 382 , 383 , 384 , 385 , 386 , 387 , 389 , 390 , 391 , 396 , 397 , 398 , 399 , 400 , 401 , 451 , 452 , 453 , 454 , 455 , 456 , 457 , 458 , 459 , 460 , 461 , 462 , 463 , 464 , 465 , 466 , 467 , 468 , 469 , 470 , 471 , 472 , 473 , 474 , 541 , 614 , 615 , 616 , 617 , 620 , 621 , 622 , 624 , 731 , 740 , 754 , 775 , 776 , 777 , 778 , 779 , 780 , 781 , 824 , 826 , 853 , 854 , 860 , 861 , 868 , 869 , 870 , 989 , 1014 , 1047 , 1068 , 1069 , 1070 , 1071 , 1072 , 1073 , 1074 , 1075 , 1076 , 1077 , 1078 , 1079 , 1080 , 1081 , 1082 , 1084 , 1085 , 1086 , 1087 , 1117 , 1123 , 1125 , 1128 , 1130 , 1131 , 1132 , 1144 , 1145 , 1155 , 1156 , 1159 , 1160 , 1161 , 1162 , 1163 , 1174 , 1175 , 1176 , 1177 , 1178 , 1183 , 1184 , 1185 , 1186 , 1187 , 1188 , 1196 , 1197 , 1198 , 1199 , 1205 , 1206 , 1207 , 1212 , 1214 , 1215 , 1216 , 1217 , 1218 , 1234 , 1235 , 1236 , 1237 , 1239 , 1242 , 1243 , 1244 , 1245 , 1246 , 1248 , 1249 , 1250 , 1254 ) , LXF-289 (pulmonary) ( 1140 ) , lymphoid-blood ( 1247 ) , M059K (glial) ( 1224 ) , MCF-10A (breast cell) ( 1261 ) , MCF-7 (breast cell) ( 394 , 837 , 1265 , 1267 ) , MCF10A1 (epithelial) ( 3 ) , MDA-MB-435S (breast cell) ( 610 ) , MG63 (bone cell) ( 34 , 1019 ) , MKN-1 (gastric) ( 993 ) , MKN-45 (gastric) ( 31 , 87 , 88 , 89 , 132 , 133 , 134 , 135 , 315 , 356 , 1012 ) , MKN-74 (gastric) ( 1006 ) , MM (B lymphocyte) ( 1255 ) , MNNG-HOS (bone cell) ( 34 ) , MRC5 (fibroblast) ( 8 ) , muscle ( 34 ) , MV4-11 (macrophage) ( 610 ) , myeloid-bone marrow ( 1118 , 1119 , 1120 , 1121 , 1122 , 1157 , 1158 , 1170 , 1173 , 1182 ) , NCCIT (epithelial) ( 395 ) , NCI-H1299 (pulmonary) ( 22 , 1222 ) , NCI-H1355 (pulmonary) ( 21 ) , NCI-H1435 (pulmonary) ( 1202 ) , NCI-H1437 (pulmonary) ( 26 , 27 , 251 , 1240 ) , NCI-H1650 (pulmonary) ( 23 , 39 , 40 , 41 , 42 , 43 , 141 , 147 , 148 , 1220 , 1264 ) , NCI-H1651 (pulmonary) ( 1223 ) , NCI-H1666 (pulmonary) ( 27 , 1012 , 1230 ) , NCI-H1693 (pulmonary) ( 1226 ) , NCI-H1703 (squamous) ( 24 , 32 , 52 , 629 , 630 , 631 , 632 , 730 , 1060 , 1061 , 1253 , 1263 ) , NCI-H1734 (pulmonary) ( 22 , 1012 , 1219 ) , NCI-H1781 (pulmonary) ( 25 ) , NCI-H1792 (pulmonary) ( 21 , 762 ) , NCI-H1793 (pulmonary) ( 1227 ) , NCI-H1838 (pulmonary) ( 1142 , 1190 ) , NCI-H1869 (squamous) ( 1211 ) , NCI-H1944 (pulmonary) ( 22 ) , NCI-H1975 (pulmonary) ( 23 , 1012 , 1229 ) , NCI-H2023 (pulmonary) ( 1225 ) , NCI-H2030 (pulmonary) ( 1193 ) , NCI-H2052 (pulmonary) ( 1141 ) , NCI-H2073 (pulmonary) ( 24 , 26 ) , NCI-H2085 (pulmonary) ( 1172 ) , NCI-H209 (pulmonary) ( 26 ) , NCI-H2106 (pulmonary) ( 23 ) , NCI-H2228 (pulmonary) ( 25 , 29 ) , NCI-H2286 (pulmonary) ( 1192 ) , NCI-H23 (pulmonary) ( 21 ) , NCI-H2342 (pulmonary) ( 24 ) , NCI-H2405 (pulmonary) ( 27 ) , NCI-H292 (pulmonary) ( 92 ) , NCI-H3122 (pulmonary) ( 25 , 142 , 149 , 150 ) , NCI-H358 (pulmonary) ( 22 , 814 , 1012 , 1228 ) , NCI-H441 (pulmonary) ( 21 ) , NCI-H446 (pulmonary) ( 20 ) , NCI-H460 (pulmonary) ( 22 ) , NCI-H526 (pulmonary) ( 20 ) , NCI-H661 (pulmonary) ( 25 , 1238 ) , NCI-H69 (pulmonary) ( 20 ) , NCI-H82 (pulmonary) ( 20 ) , NCI-H838 (pulmonary) ( 26 ) , nerve ( 34 ) , NOMO-1 (myeloid) ( 256 ) , NUGC-2 (gastric) ( 1005 ) , OCI/AML3 (myeloid) ( 7 ) , ovary ( 279 , 280 , 281 , 282 , 283 , 284 , 294 , 295 , 367 , 368 , 369 , 370 , 371 , 372 , 373 , 374 , 405 , 408 , 409 , 410 , 411 , 412 , 413 , 414 , 415 , 416 , 417 , 418 , 419 , 420 , 421 , 422 , 423 , 1023 , 1024 , 1025 , 1026 , 1028 , 1029 , 1030 , 1031 ) , OVCAR8 (ovarian) ( 287 ) , OVMANA (ovarian) ( 210 , 262 ) , OVTOKO (ovarian) ( 264 , 285 ) , pancreas ( 625 , 626 , 980 ) , PC3 (prostate cell) ( 823 ) , PLC/PRF/5 (hepatic) ( 755 ) , RC-K8 (B lymphocyte) ( 1179 ) , RD18 (muscle cell) ( 34 ) , RMUG-S (ovarian) ( 263 ) , salivary gland ( 797 , 798 , 799 , 800 , 801 , 802 , 803 , 804 , 805 , 806 , 807 , 808 , 809 , 810 , 811 ) , Saos-2 (bone cell) ( 34 ) , SH-SY5Y (neural crest) ( 9 , 265 , 266 , 296 , 297 ) , SJSA-1 (bone cell) ( 1043 ) , SK-HEP-1 (endothelial) ( 726 ) , SK-LMS-1 (muscle cell) ( 34 ) , SK-MES-1 (pulmonary) ( 1 ) , skin ( 319 , 320 , 321 , 438 , 439 , 440 , 441 , 442 , 443 , 444 , 445 , 446 , 773 , 784 , 785 , 786 , 815 , 816 , 889 , 890 , 891 , 892 ) , SKNFI (neural crest) ( 1134 ) , SMS-KCN-A (neural crest) ( 9 ) , SNU-1079 (hepatic) ( 790 ) , SNU-1196 (hepatic) ( 788 ) , SNU-182 (hepatic) ( 873 ) , SNU-398 (hepatic) ( 789 ) , SNU-449 (hepatic) ( 725 ) , SNU-C2B (intestinal) ( 1146 , 1147 ) , spleen ( 992 ) , stomach ( 482 , 483 , 484 , 485 , 486 , 487 , 488 , 489 , 490 , 491 , 492 , 493 , 494 , 495 , 496 , 497 , 498 , 499 , 500 , 501 , 502 , 503 , 504 , 838 , 839 , 840 , 841 , 842 , 843 , 844 , 845 , 846 , 847 , 848 , 849 , 850 , 851 , 855 , 856 , 857 , 858 , 859 , 862 , 863 , 864 , 865 , 866 , 867 , 970 , 971 , 972 , 973 , 974 , 982 , 983 , 984 , 985 , 986 , 988 , 990 , 991 , 1001 ) , Su.86.86 (pancreatic) ( 1262 ) , SW-1573 (pulmonary) ( 1013 ) , SW1088 (glial) ( 1189 ) , SW1783 (glial) ( 1191 ) , SW48 (intestinal) ( 1154 ) , SW480 (intestinal) ( 304 , 1016 , 1017 ) , SW620 (intestinal) ( 304 ) , SW780 (bladder cell) ( 1089 ) , T1-73 (bone cell) ( 1044 ) , THP1 (myeloid) ( 7 ) , thymus ( 178 , 179 ) , thyroid ( 905 , 906 , 960 , 961 , 962 , 995 , 996 , 997 , 998 , 999 ) , U-118MG (glial) ( 145 , 146 , 154 , 818 ) , U2OS (bone cell) ( 1015 ) , U87MG (glial) [EGFR (human), transfection] ( 288 ) , UM-UC-1 (bladder cell) ( 1135 ) , UT-7 (myeloid) ( 1268 ) , VACO432 (ovarian) ( 1203 )

Upstream Regulation
Regulatory protein:
ANG (human) ( 12 ) , CAD (human) ( 10 ) , CARD11 (human) ( 1083 ) , DYN2 (human) ( 1256 ) , E4 (adenovirus) ( 837 ) , FGFR1 (human) ( 579 ) , JIP3 (human) ( 1015 , 1233 ) , JNK1 (human) ( 1267 ) , JNK1 (mouse) ( 13 ) , JNK2 (human) ( 252 , 1267 ) , JNK2 iso2 (human) ( 252 ) , MKK4 (human) ( 1200 ) , MLK3 (human) ( 878 ) , NDFIP1 (human) ( 303 ) , NDFIP2 (human) ( 303 ) , PKCE (human) ( 271 ) , PPP1CA (human) ( 825 ) , PPP2CA (human) ( 825 ) , ROCK1 (human) ( 1015 ) , SHP-2 (human) ( 736 ) , SHPS1 (human) ( 288 ) , TRIM45 (human) ( 11 )
Putative in vivo kinases:
MKK4 (human) ( 1233 )
Kinases, in vitro:
MKK4 (human) ( 1269 ) , Ret (human) ( 1231 )
Treatments:
1,25D ( 7 ) , 15d-PGJ2 ( 871 ) , 9F7-F11 ( 4 ) , ABT-737 ( 10 ) , AG1478 ( 288 ) , anisomycin ( 994 , 1266 , 1269 ) , anti-CD3/CD28 ( 1083 ) , antigenic stimulation ( 1256 ) , arsenite ( 1266 , 1267 ) , bacterial infection ( 825 ) , bortezomib ( 1255 ) , calyculin_A ( 825 ) , cGMP_analog ( 304 ) , colchicine ( 1267 ) , defactinib ( 1 ) , dimethylfumarate ( 15 ) , dronabinol ( 1013 ) , EGF ( 303 , 878 , 1013 , 1200 ) , Epo ( 1268 ) , estradiol ( 394 ) , glucose_starvation ( 1233 ) , H2O2 ( 1213 ) , HGF ( 139 ) , IL-15 ( 19 ) , IL-1a ( 1269 ) , IL-2 ( 19 ) , IL-3 ( 1268 ) , IL-6 ( 1067 ) , insulin ( 994 , 1067 ) , ionomycin ( 1083 ) , ischemia ( 18 ) , JNK_inhibitor_I ( 1067 ) , LY2090314 ( 14 ) , LY294002 ( 394 ) , N65828 ( 12 ) , NAC ( 871 ) , neuregulin ( 4 ) , nocodazole ( 1267 ) , NSC23766 ( 837 ) , NVP-BKM120 ( 1 ) , okadaic_acid ( 479 , 825 ) , osmotic_stress ( 1269 ) , PD98059 ( 1067 , 1266 ) , phorbol_ester ( 1083 ) , pneumolysin ( 825 ) , Q-VD-OPh ( 10 ) , SB203580 ( 994 , 1266 ) , SB415286 ( 7 ) , secramine_A ( 837 ) , serum ( 11 ) , silibinin ( 823 ) , siRNA ( 878 , 1267 ) , sorbitol ( 252 , 1083 ) , SP600125 ( 8 , 479 , 994 , 1213 , 1267 ) , taxol ( 13 ) , TNF ( 15 , 271 , 736 , 1269 ) , UV ( 1015 , 1269 ) , vanadate ( 825 ) , vinblastine ( 1267 ) , virus infection ( 8 ) , wortmannin ( 394 ) , WR1065 ( 1265 ) , Y27632 ( 837 , 1015 )

References 

1

Cavazzoni A, et al. (2017) Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN. Oncotarget 8, 53068-53083
28881794   Curated Info

2

Moles A, et al. (2016) A RelA(p65) Thr505 phospho-site mutation reveals an important mechanism regulating NF-κB-dependent liver regeneration and cancer. Oncogene 35, 4623-32
26853469   Curated Info

3

Kim DY, Helfman DM (2016) Loss of MLCK leads to disruption of cell-cell adhesion and invasive behavior of breast epithelial cells via increased expression of EGFR and ERK/JNK signaling. Oncogene 35, 4495-508
26876209   Curated Info

4

Le Clorennec C, et al. (2016) The anti-HER3 (ErbB3) therapeutic antibody 9F7-F11 induces HER3 ubiquitination and degradation in tumors through JNK1/2- dependent ITCH/AIP4 activation. Oncotarget 7, 37013-37029
27203743   Curated Info

5

Mertins P, et al. (2016) Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534, 55-62
27251275   Curated Info

6

Boeing S, et al. (2016) Multiomic Analysis of the UV-Induced DNA Damage Response. Cell Rep 15, 1597-1610
27184836   Curated Info

7

Gupta K, et al. (2016) GSK-3 Inhibition Sensitizes Acute Myeloid Leukemia Cells to 1,25D-Mediated Differentiation. Cancer Res 76, 2743-53
26964622   Curated Info

8

Klein SR, et al. (2015) C-Jun N-terminal kinases are required for oncolytic adenovirus-mediated autophagy. Oncogene 34, 5295-301
25619840   Curated Info

9

Palacios-Moreno J, et al. (2015) Neuroblastoma Tyrosine Kinase Signaling Networks Involve FYN and LYN in Endosomes and Lipid Rafts. PLoS Comput Biol 11, e1004130
25884760   Curated Info

10

Ichim G, et al. (2015) Limited mitochondrial permeabilization causes DNA damage and genomic instability in the absence of cell death. Mol Cell 57, 860-72
25702873   Curated Info

11

Sato T, et al. (2015) The TRIM-FLMN protein TRIM45 directly interacts with RACK1 and negatively regulates PKC-mediated signaling pathway. Oncogene 34, 1280-91
24681954   Curated Info

12

Miyake M, et al. (2015) Angiogenin promotes tumoral growth and angiogenesis by regulating matrix metallopeptidase-2 expression via the ERK1/2 pathway. Oncogene 34, 890-901
24561529   Curated Info

13

Yin B, et al. (2015) The TrkB+ cancer stem cells contribute to post-chemotherapy recurrence of triple-negative breast cancers in an orthotopic mouse model. Oncogene 34, 761-70
24531713   Curated Info

14

Atkinson JM, et al. (2015) Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma--Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3. PLoS One 10, e0125028
25915038   Curated Info

15

Gerhardt S, et al. (2015) Dimethylfumarate protects against TNF-α-induced secretion of inflammatory cytokines in human endothelial cells. J Inflamm (Lond) 12, 49
26246800   Curated Info

16

Johnson H, White FM (2014) Quantitative analysis of signaling networks across differentially embedded tumors highlights interpatient heterogeneity in human glioblastoma. J Proteome Res 13, 4581-93
24927040   Curated Info

17

Yoshida T, et al. (2014) Tyrosine phosphoproteomics identifies both codrivers and cotargeting strategies for T790M-related EGFR-TKI resistance in non-small cell lung cancer. Clin Cancer Res 20, 4059-74
24919575   Curated Info

18

Mertins P, et al. (2014) Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics 13, 1690-704
24719451   Curated Info

19

Arneja A, et al. (2014) Qualitatively different T cell phenotypic responses to IL-2 versus IL-15 are unified by identical dependences on receptor signal strength and duration. J Immunol 192, 123-35
24298013   Curated Info

20

Rikova K, Hall B (2013) CST Curation Set: 20735, 21162, 30155, 30156, 30157; Year: 2013; Biosample/Treatment: cell line, DMS53, H526, H69, H82, H446; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

21

Rikova K, Hall B (2013) CST Curation Set: 20736, 21163, 30158, 30159, 30160; Year: 2013; Biosample/Treatment: cell line, A549, H1355, H23, H441, H1792; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

22

Rikova K, Hall B (2013) CST Curation Set: 20737, 21164, 30161, 30162, 30163; Year: 2013; Biosample/Treatment: cell line, H1299, H1944, H358, H1734, H460; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

23

Rikova K, Hall B (2013) CST Curation Set: 20738, 21165, 30164, 30165, 30166; Year: 2013; Biosample/Treatment: cell line, H1650, HCC827, H1975, Calu-3, H2106; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

24

Rikova K, Hall B (2013) CST Curation Set: 20739, 21166, 30167, 30168, 30169; Year: 2013; Biosample/Treatment: cell line, H2342, H2073, Lou-NH91, HCC15, H1703; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

25

Rikova K, Hall B (2013) CST Curation Set: 20740, 21167, 30170, 30171, 30172; Year: 2013; Biosample/Treatment: cell line, H2228, H3122, HCC78, H661, H1781; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

26

Rikova K, Hall B (2013) CST Curation Set: 20742, 21169, 30176, 30177, 30178; Year: 2013; Biosample/Treatment: cell line, H838, DMS153, H2073, H209, H1437; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

27

Rikova K, Hall B (2013) CST Curation Set: 20741, 21168, 30173, 30174, 30175; Year: 2013; Biosample/Treatment: cell line, H1666, CAL-12T, H2405, HCC44, H1437; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY, p[ST], RXXp[ST], pSQ, p[ST]QG, LXRXXp[ST], p[ST]P
Curated Info

28

Mertins P, et al. (2013) Integrated proteomic analysis of post-translational modifications by serial enrichment. Nat Methods 10, 634-7
23749302   Curated Info

29

Rikova K (2013) CST Curation Set: 18449; Year: 2012; Biosample/Treatment: cell line, H2228/crizotinib, geldanamycin; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) MultiMab(TM) Rabbit mAb mix Cat#: 8954
Curated Info

30

Helou YA, Nguyen V, Beik SP, Salomon AR (2013) ERK positive feedback regulates a widespread network of tyrosine phosphorylation sites across canonical T cell signaling and actin cytoskeletal proteins in Jurkat T cells. PLoS One 8, e69641
23874979   Curated Info

31

Rikova K (2012) CST Curation Set: 16137; Year: 2012; Biosample/Treatment: cell line, MKN45/crizotinib; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) MultiMab(TM) Rabbit mAb mix Cat#: 8954
Curated Info

32

Rikova K (2012) CST Curation Set: 16139; Year: 2012; Biosample/Treatment: cell line, H1703/gleevec; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) MultiMab(TM) Rabbit mAb mix Cat#: 8954
Curated Info

33

Manser C, et al. (2012) Lemur tyrosine kinase-2 signalling regulates kinesin-1 light chain-2 phosphorylation and binding of Smad2 cargo. Oncogene 31, 2773-82
21996745   Curated Info

34

Bai Y, et al. (2012) Phosphoproteomics identifies driver tyrosine kinases in sarcoma cell lines and tumors. Cancer Res 72, 2501-11
22461510   Curated Info

35

Zhou J (2012) CST Curation Set: 14432; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

36

Stokes MP, et al. (2012) PTMScan Direct: Identification and Quantification of Peptides from Critical Signaling Proteins by Immunoaffinity Enrichment Coupled with LC-MS/MS. Mol Cell Proteomics 11, 187-201
22322096   Curated Info

37

Rikova K (2012) CST Curation Set: 14270; Year: 2012; Biosample/Treatment: cell line, Tumor pilot study 1mg/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

38

Rikova K (2012) CST Curation Set: 14271; Year: 2012; Biosample/Treatment: cell line, Tumor pilot study 2mg/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

39

Possemato A (2012) CST Curation Set: 14060; Year: 2012; Biosample/Treatment: cell line, H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

40

Possemato A (2012) CST Curation Set: 14061; Year: 2012; Biosample/Treatment: cell line, H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

41

Possemato A (2012) CST Curation Set: 14062; Year: 2012; Biosample/Treatment: cell line, H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

42

Possemato A (2012) CST Curation Set: 14058; Year: 2012; Biosample/Treatment: cell line, H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

43

Possemato A (2012) CST Curation Set: 14059; Year: 2012; Biosample/Treatment: cell line, H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

44

Tucker M (2012) CST Curation Set: 13493; Year: 2012; Biosample/Treatment: cell line, 23132/87[RAIG1(knockdown)]/GPRC5A knockdown; Disease: gastric cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

45

Tucker M (2012) CST Curation Set: 13494; Year: 2012; Biosample/Treatment: cell line, 23132/87/untreated; Disease: gastric cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

46

Lakshmanan I, et al. (2012) MUC16 induced rapid G2/M transition via interactions with JAK2 for increased proliferation and anti-apoptosis in breast cancer cells. Oncogene 31, 805-17
21785467   Curated Info

47

Mulhern D (2012) CST Curation Set: 13107; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

48

Mulhern D (2012) CST Curation Set: 13108; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

49

Mulhern D (2012) CST Curation Set: 13112; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

50

Rikova K (2012) CST Curation Set: 13730; Year: 2012; Biosample/Treatment: cell line, Mix of TMT treated cell lines 2/treated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

51

Rikova K (2012) CST Curation Set: 13729; Year: 2012; Biosample/Treatment: cell line, Mix of TMT treated cell lines 1/treated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

52

Possemato A (2012) CST Curation Set: 13553; Year: 2012; Biosample/Treatment: cell line, NCI-H1703/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

53

Possemato A (2012) CST Curation Set: 13559; Year: 2012; Biosample/Treatment: cell line, mixTMT(A549,H3255,MKN45,H3122,,H1703,H1650)/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

54

Tucker M (2012) CST Curation Set: 13495; Year: 2012; Biosample/Treatment: cell line, Colo-680N[RAIG1(knockdown)]/GPRC5A knockdown; Disease: esophageal cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

55

Tucker M (2012) CST Curation Set: 13496; Year: 2012; Biosample/Treatment: cell line, Colo-680N[RAIG1(knockdown)]/GPRC5A knockdown; Disease: esophageal cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

56

Tucker M (2012) CST Curation Set: 13497; Year: 2012; Biosample/Treatment: cell line, Colo-680N/untreated; Disease: esophageal cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

57

Zhou J (2012) CST Curation Set: 12609; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

58

Zhou J (2012) CST Curation Set: 12610; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

59

Mulhern D (2012) CST Curation Set: 13337; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

60

Mulhern D (2012) CST Curation Set: 13338; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

61

Mulhern D (2012) CST Curation Set: 13339; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[ST]P
Curated Info

62

Mulhern D (2012) CST Curation Set: 13340; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[ST]P
Curated Info

63

Mulhern D (2012) CST Curation Set: 13335; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

64

Mulhern D (2012) CST Curation Set: 13336; Year: 2012; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

65

Rikova K (2012) CST Curation Set: 13324; Year: 2012; Biosample/Treatment: cell line, A549/untreated; Disease: lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

66

Mulhern D (2012) CST Curation Set: 13331; Year: 2012; Biosample/Treatment: cell line, HCT 116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

67

Mulhern D (2012) CST Curation Set: 13332; Year: 2012; Biosample/Treatment: cell line, HCT 116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

68

Mulhern D (2012) CST Curation Set: 13333; Year: 2012; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) Rabbit mAb Cat#: 8954, Phospho-Tyrosine Rabbit mAb (p-Tyr-1000) Immunoaffinity Beads Cat#: 8876
Curated Info

69

Mulhern D (2011) CST Curation Set: 13106; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

70

Mulhern D (2011) CST Curation Set: 13111; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

71

Rikova K (2011) CST Curation Set: 13117; Year: 2011; Biosample/Treatment: cell line, MGH-5/unknown; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

72

Mulhern D (2011) CST Curation Set: 12687; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

73

Mulhern D (2011) CST Curation Set: 12689; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

74

Mulhern D (2011) CST Curation Set: 12691; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

75

Mulhern D (2011) CST Curation Set: 12695; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

76

Mulhern D (2011) CST Curation Set: 12697; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

77

Mulhern D (2011) CST Curation Set: 13031; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

78

Mulhern D (2011) CST Curation Set: 13033; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

79

Mulhern D (2011) CST Curation Set: 12641; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[ST]P
Curated Info

80

Mulhern D (2011) CST Curation Set: 12642; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[ST]P
Curated Info

81

Mulhern D (2011) CST Curation Set: 12643; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

82

Mulhern D (2011) CST Curation Set: 12644; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

83

Mulhern D (2011) CST Curation Set: 12578; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

84

Mulhern D (2011) CST Curation Set: 12579; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

85

Mulhern D (2011) CST Curation Set: 12580; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

86

Mulhern D (2011) CST Curation Set: 12582; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

87

Moritz A (2011) CST Curation Set: 12517; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

88

Moritz A (2011) CST Curation Set: 12518; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

89

Moritz A (2011) CST Curation Set: 12519; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

90

Mulhern D (2011) CST Curation Set: 12550; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[ST]P
Curated Info

91

Mulhern D (2011) CST Curation Set: 12552; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[ST]P
Curated Info

92

Li C, et al. (2011) Oncogenic role of EAPII in lung cancer development and its activation of the MAPK-ERK pathway. Oncogene 30, 3802-12
21478903   Curated Info

93

Mulhern D (2011) CST Curation Set: 12471; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

94

Mulhern D (2011) CST Curation Set: 12472; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

95

Mulhern D (2011) CST Curation Set: 12473; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

96

Mulhern D (2011) CST Curation Set: 12474; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

97

Mulhern D (2011) CST Curation Set: 12475; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

98

Zhou J (2011) CST Curation Set: 12341; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

99

Zhou J (2011) CST Curation Set: 12342; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

100

Zhou J (2011) CST Curation Set: 12343; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

101

Zhou J (2011) CST Curation Set: 12344; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

102

Zhou J (2011) CST Curation Set: 12346; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

103

Zhou J (2011) CST Curation Set: 12347; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

104

Zhou J (2011) CST Curation Set: 12348; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

105

Mulhern D (2011) CST Curation Set: 12399; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

106

Mulhern D (2011) CST Curation Set: 12400; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

107

Mulhern D (2011) CST Curation Set: 12401; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

108

Mulhern D (2011) CST Curation Set: 12402; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

109

Mulhern D (2011) CST Curation Set: 12428; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

110

Mulhern D (2011) CST Curation Set: 12429; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

111

Mulhern D (2011) CST Curation Set: 12430; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

112

Mulhern D (2011) CST Curation Set: 12431; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

113

Mulhern D (2011) CST Curation Set: 12432; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

114

Mulhern D (2011) CST Curation Set: 12434; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

115

Mulhern D (2011) CST Curation Set: 12439; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[ST]P
Curated Info

116

Mulhern D (2011) CST Curation Set: 12440; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[ST]P
Curated Info

117

Mulhern D (2011) CST Curation Set: 12443; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[ST]P
Curated Info

118

Guo A (2011) CST Curation Set: 12074; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: (F/Y/M)Xp[ST](L/I/M)
Curated Info

119

Zhou J (2011) CST Curation Set: 12314; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

120

Zhou J (2011) CST Curation Set: 12316; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

121

Zhou J (2011) CST Curation Set: 12317; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

122

Zhou J (2011) CST Curation Set: 12318; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

123

Zhou J (2011) CST Curation Set: 12319; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY
Curated Info

124

Zhou J (2011) CST Curation Set: 12320; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

125

Guo A (2011) CST Curation Set: 12174; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]
Curated Info

126

Zhou J (2011) CST Curation Set: 12026; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY(YXXM) Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Tyr) p85 PI3K Binding Motif Antibody Cat#: 3821
Curated Info

127

Zhou J (2011) CST Curation Set: 12029; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY(YXXM) Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Tyr) p85 PI3K Binding Motif Antibody Cat#: 3821
Curated Info

128

Zhou J (2011) CST Curation Set: 12030; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY(YXXM) Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Tyr) p85 PI3K Binding Motif Antibody Cat#: 3821
Curated Info

129

Zhou J (2011) CST Curation Set: 12031; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY(YXXM) Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Tyr) p85 PI3K Binding Motif Antibody Cat#: 3821
Curated Info

130

Zhou J (2011) CST Curation Set: 12032; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY(YXXM) Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Tyr) p85 PI3K Binding Motif Antibody Cat#: 3821
Curated Info

131

Zhou J (2011) CST Curation Set: 12033; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY(YXXM) Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Tyr) p85 PI3K Binding Motif Antibody Cat#: 3821
Curated Info

132

Moritz A (2011) CST Curation Set: 12370; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

133

Moritz A (2011) CST Curation Set: 12372; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

134

Moritz A (2011) CST Curation Set: 12373; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

135

Moritz A (2011) CST Curation Set: 12374; Year: 2011; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

136

Guo A (2011) CST Curation Set: 12017; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[ST]P
Curated Info

137

Guo A (2011) CST Curation Set: 12018; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[ST]P
Curated Info

138

Guo A (2011) CST Curation Set: 12024; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[ST]P
Curated Info

139

Organ SL, et al. (2011) Quantitative Phospho-Proteomic Profiling of Hepatocyte Growth Factor (HGF)-MET Signaling in Colorectal Cancer. J Proteome Res 10, 3200-11
21609022   Curated Info

140

Wang J, Zhou JY, Wu GS (2011) Bim protein degradation contributes to cisplatin resistance. J Biol Chem 286, 22384-92
21561860   Curated Info

141

Possemato A (2011) CST Curation Set: 11906; Year: 2011; Biosample/Treatment: cell line, NCI-H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

142

Possemato A (2011) CST Curation Set: 11908; Year: 2011; Biosample/Treatment: cell line, NCI-H3122/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

143

Possemato A (2011) CST Curation Set: 11909; Year: 2011; Biosample/Treatment: cell line, HCC78/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

144

Possemato A (2011) CST Curation Set: 11910; Year: 2011; Biosample/Treatment: cell line, HCC78/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

145

Possemato A (2011) CST Curation Set: 11915; Year: 2011; Biosample/Treatment: cell line, U118 MG/untreated; Disease: astrocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

146

Possemato A (2011) CST Curation Set: 11916; Year: 2011; Biosample/Treatment: cell line, U118 MG/untreated; Disease: astrocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

147

Possemato A (2011) CST Curation Set: 11917; Year: 2011; Biosample/Treatment: cell line, NCI-H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

148

Possemato A (2011) CST Curation Set: 11918; Year: 2011; Biosample/Treatment: cell line, NCI-H1650/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

149

Possemato A (2011) CST Curation Set: 11919; Year: 2011; Biosample/Treatment: cell line, NCI-H3122/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

150

Possemato A (2011) CST Curation Set: 11920; Year: 2011; Biosample/Treatment: cell line, NCI-H3122/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

151

Possemato A (2011) CST Curation Set: 11921; Year: 2011; Biosample/Treatment: cell line, HCC78/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

152

Possemato A (2011) CST Curation Set: 11922; Year: 2011; Biosample/Treatment: cell line, HCC78/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

153

Possemato A (2011) CST Curation Set: 11923; Year: 2011; Biosample/Treatment: cell line, HCT116/untreated; Disease: colorectal carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

154

Possemato A (2011) CST Curation Set: 11927; Year: 2011; Biosample/Treatment: cell line, U118 MG/untreated; Disease: astrocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

155

Guo A (2011) CST Curation Set: 11646; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

156

Guo A (2011) CST Curation Set: 11647; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

157

Guo A (2011) CST Curation Set: 11648; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

158

Ren H (2011) CST Curation Set: 11774; Year: 2011; Biosample/Treatment: cell line, RP91/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

159

Ren H (2011) CST Curation Set: 11775; Year: 2011; Biosample/Treatment: cell line, RP92/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

160

Ren H (2011) CST Curation Set: 11777; Year: 2011; Biosample/Treatment: cell line, RP94/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

161

Ren H (2011) CST Curation Set: 11778; Year: 2011; Biosample/Treatment: cell line, RP95/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

162

Ren H (2011) CST Curation Set: 11779; Year: 2011; Biosample/Treatment: cell line, RP96/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

163

Ren H (2011) CST Curation Set: 11780; Year: 2011; Biosample/Treatment: cell line, RP97/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

164

Ren H (2011) CST Curation Set: 11781; Year: 2011; Biosample/Treatment: cell line, RP98/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

165

Ren H (2011) CST Curation Set: 11783; Year: 2011; Biosample/Treatment: cell line, RP100/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

166

Ren H (2011) CST Curation Set: 11784; Year: 2011; Biosample/Treatment: cell line, RP101/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

167

Ren H (2011) CST Curation Set: 11785; Year: 2011; Biosample/Treatment: cell line, RP102/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

168

Ren H (2011) CST Curation Set: 11786; Year: 2011; Biosample/Treatment: cell line, RP103/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

169

Ren H (2011) CST Curation Set: 11787; Year: 2011; Biosample/Treatment: cell line, RP104/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

170

Ren H (2011) CST Curation Set: 11788; Year: 2011; Biosample/Treatment: cell line, RP105/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

171

Ren H (2011) CST Curation Set: 11790; Year: 2011; Biosample/Treatment: cell line, FAC 13N/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

172

Ren H (2011) CST Curation Set: 11791; Year: 2011; Biosample/Treatment: cell line, FAC 13T/untreated; Disease: non-small cell lung adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

173

Possemato A (2011) CST Curation Set: 11711; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

174

Possemato A (2011) CST Curation Set: 11712; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

175

Possemato A (2011) CST Curation Set: 11713; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

176

Possemato A (2011) CST Curation Set: 11714; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

177

Possemato A (2011) CST Curation Set: 11718; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

178

Li Y (2011) CST Curation Set: 10459; Year: 2011; Biosample/Treatment: tissue, thymus/untreated; Disease: thymic carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

179

Li Y (2011) CST Curation Set: 10460; Year: 2011; Biosample/Treatment: tissue, thymus/untreated; Disease: thymic carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

180

Li Y (2011) CST Curation Set: 10514; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

181

Li Y (2011) CST Curation Set: 10515; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

182

Li Y (2011) CST Curation Set: 10516; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

183

Li Y (2011) CST Curation Set: 10517; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

184

Li Y (2011) CST Curation Set: 10518; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

185

Li Y (2011) CST Curation Set: 10519; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

186

Li Y (2011) CST Curation Set: 10520; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

187

Li Y (2011) CST Curation Set: 10521; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

188

Li Y (2011) CST Curation Set: 10522; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

189

Li Y (2011) CST Curation Set: 10523; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

190

Li Y (2011) CST Curation Set: 10524; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

191

Li Y (2011) CST Curation Set: 10525; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

192

Li Y (2011) CST Curation Set: 10526; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

193

Li Y (2011) CST Curation Set: 10527; Year: 2011; Biosample/Treatment: tissue, heart/untreated; Disease: ventricular tachycardia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

194

Possemato A (2011) CST Curation Set: 11628; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

195

Possemato A (2011) CST Curation Set: 11629; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

196

Possemato A (2011) CST Curation Set: 11632; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

197

Possemato A (2011) CST Curation Set: 11633; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info